77 articles
Array Biopharma Inc. challenged the Deputy Controller of Patents' refusal of its pharmaceutical combination patent for a cancer therapy before the Delhi High Court. Did the Controller's reasoning…
The Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM) has released Draft Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals, 2026…
Esteve Pharmaceuticals took its rejected co-crystal patent for tramadol and celecoxib to the Delhi High Court, arguing the combination showed real synergy. The court had to decide whether…
In Deepak Nitrite Limited v. The Assistant Controller General of Patents and Designs, the Bombay High Court set aside a Section 15 refusal that rested on an unsourced…
NEC Corporation's appeal over the refusal of its video coding patent has been dismissed by the Delhi High Court, which confirmed that the invention lacks inventive step under…
Sulzer Mixpac appealed the rejection of its static mixer patent to the Delhi High Court, arguing its own prior patents did not anticipate the claimed design. The court…
The Delhi High Court dismissed BlackBerry's appeal against the refusal of its patent for colour-coding email recipients on handheld devices, holding that the invention lacked inventive step and…
Titan Company Limited took its rejected “Jewellery Assembly” application to the Madras High Court, testing whether a cost-saving gemstone arrangement was patent or design subject matter. Did the…
In the case of Shaafi Naturcure LLP v Assistant Controller of Patents and Designs, the applicant claimed that six known herbs, when combined in specific proportions, produced a…
Daewoong Pharmaceutical challenged the Controller's rejection of its crystalline SGLT inhibitor patent before the Delhi High Court. The core question: does improved dissolution and stability satisfy the Section…